Montecito Bank & Trust’s AstraZeneca AZN Stock Holding History

Montecito Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,492	Closed	-$1.19M	–	268
2025 Q4	$1.19M	Sell	6,492 -1,647	-20%	-$289K	0.19%	119
2025 Q3	$1.25M	Buy	+8,139	New	+$1.23M	0.19%	119
2025 Q1	$624K	Buy	4,242 +2,164	+104%	+$313K	0.11%	180
2024 Q4	$272K	Buy	2,078 +533	+34%	+$74.6K	0.05%	247
2024 Q3	$241K	Hold	1,545	–	–	0.04%	262
2024 Q2	$241K	Hold	1,545	–	–	0.05%	243
2024 Q1	$209K	Sell	1,545 -619	-29%	-$82K	0.04%	259
2023 Q4	$291K	Hold	2,164	–	–	0.06%	220
2023 Q3	$293K	Hold	2,164	–	–	0.07%	205
2023 Q2	$310K	Hold	2,164	–	–	0.07%	204
2023 Q1	$300K	Buy	2,164 +50	+2%	+$6.73K	0.07%	206
2022 Q4	$287K	Sell	2,114 -68	-3%	-$8.53K	0.07%	205
2022 Q3	$239K	Hold	2,182	–	–	0.06%	216
2022 Q2	$288K	Hold	2,182	–	–	0.07%	203
2022 Q1	$289K	Hold	2,182	–	–	0.05%	230
2021 Q4	$254K	Hold	2,182	–	–	0.05%	240
2021 Q3	$262K	Buy	+2,182	New	+$254K	0.05%	239

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Montecito Bank & Trust's AZN Position: Q1 2026 in Review

Montecito Bank & Trust sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 6,492 shares — an estimated $1.19M sold.

Montecito Bank & Trust first reported a position in AZN in Q3 2021 and held it in 17 quarters. The position peaked at $1.25M in Q3 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Montecito Bank & Trust reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Montecito Bank & Trust sold 6,492 AstraZeneca shares in Q1 2026, an estimated $1.19M.
Montecito Bank & Trust first reported a position in AstraZeneca in Q3 2021 and held it in 17 quarters.
Montecito Bank & Trust's AstraZeneca position peaked at $1.25M in Q3 2025.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Montecito Bank & Trust's 13F filing for Q1 2026, filed 16 Apr 2026.